<DOC>
	<DOCNO>NCT00550225</DOCNO>
	<brief_summary>Salt Bridging study GSK961081</brief_summary>
	<brief_title>Succinate Salt Version GSK961081 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Healthy adult male female age 18 50 year . Body mass index within range 1929.9 kilograms/metre2 Forced Expiratory Volume 1 second ( FEV1 ) &gt; 80 % predict FEV1/ Forced Vital Capacity ( FVC ) ratio &gt; 0.7 Subjects current nonsmoker use tobacco product 6month period precede screen visit pack history &lt; 10 pack year . Exclusion criterion : Who past present disease , judge Investigator medical monitor may affect outcome study safety subject History respiratory disease Significant abnormal 12 lead ECG , QTc ( B ) QTc ( F ) value screen &gt; 450msec individual ECG PR interval outside range 120210 msec Supine mean heart rate outside range 4090 beat per minute ( bpm ) screening . Subject donate unit blood within 56 day intend donate within 56 day complete study Subject currently take regular ( course ) medication whether prescribed ( exception contraceptive , include vitamin herbal remedy St John 's Wort . Subject participate clinical study New Chemical Entity ( NCE ) within past 3 month Infected Hepatitis B , Hepatitis C , HIV virus Subject history drug allergy , , opinion Investigator , contraindicate participation</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>succinate</keyword>
	<keyword>anti-muscarinic</keyword>
	<keyword>b-agonist</keyword>
</DOC>